Abstract
The prevalence of acute kidney injury (AKI) in the US is increasing, which can be attributed in part to the aging population and the pandemic of obesity, diabetes and hypertension. Individuals over the age of 70 years constitute 7% of the US population, but account for 36–70% of AKI cases. Presently, major efforts are underway to enable the early detection of AKI by use of various innovative biomarkers, thereby facilitating early intervention. Now is the time, therefore, to consider potential interventions to attenuate or prevent AKI. Several randomized studies have failed to alter the course of AKI, but these studies have been complicated by extrarenal consequences, which could have obscured the potential intrarenal benefit of the agent. Thus, agents that have exclusive effects on renal hemodynamics and tubular function, or the intrarenal infusion of short-acting agents that do not have systemic effects, need to be considered in future studies for the prevention of AKI.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
U. S. Department of Health and Human Services. National Center for Disease Control and Prevention National Center for Health Statistics, National Health Statistics Reports. No. 5, July 30 (2008).
United States Renal Disease Survey, 2006. United States Renal Data System. Annual data report, 2006 (USRDS Coordinating Center, Minneapolis, MN, 2006).
Uchino, S. et al. Acute renal failure in critically Ill patients: a multinational, multicenter study. JAMA 294, 813–818 (2005).
Waikar, S. S. & Bonventre, J. V. Biomarkers for the diagnosis of acute kidney injury. Nephron Clin. Pract. 109, c192–c197 (2008).
Nickolas, T. L. et al. Sensitivity and specificity of a single emergency department measurement of urinary neutrophil gelatinase–associated lipocalin for diagnosing acute kidney injury. Ann. Intern. Med. 148, 810–819 (2009).
Miller, T. R. et al. Urinary diagnostic indices in acute renal failure: a prospective study. Ann. Intern. Med. 89, 47–50 (1978).
Carvounis, C. P., Nisar, S. & Guro-Razuman, S. Significance of the fractional excretion of urea in the differential diagnosis of acute kidney failure. Kidney Int. 62, 2223–2229 (2002).
Pépin, M. N., Bouchard, J., Legault, L. & Éthier, J. Diagnostic performance of fractional excretion of urea and fractional excretion of sodium in the evaluations of patients with acute kidney injury with or without diuretic treatment. Am. J. Kidney Dis. 50, 566–573 (2007).
Bouchard, J. et al. Fluid accumulation, survival and recovery of kidney function in critically ill patients with acute kidney injury. Kidney Int. 76, 422–427 (2009).
Imai, Y. et al. Injurious mechanical ventilation and end-organ epithelial cell apoptosis and organ dysfunction in an experimental model of acute respiratory distress syndrome. JAMA 289, 2104–2112 (2003).
Weiderman, H. et al. Comparison of two fluid-management strategies in acute lung injury. N. Engl. J. Med. 354, 2564–2575 (2006).
Schrier, R. W., Wang, W., Poole, B. & Mitra, A. Acute renal failure: definitions, diagnosis, mechanisms, and therapy. J. Clin. Invest. 114, 5–14 (2004).
Schrier, R. W. & Wang, W. Acute renal failure and sepsis. N. Engl. J. Med. 351, 159–169 (2004).
Olson, L. J., Lowe, D. G. & Drewett, J. G. Novel natriuretic peptide receptor/guanylyl cyclase A-selective agonist inhibits angiotensin II and forskolin-evoked aldosterone synthesis in a human zona glomerulosa cell line. Mol. Pharmacol. 50, 430–435 (1996).
Marin-Grez, M., Fleming, J. T. & Steinhausen, M. Atrial natriuretic peptide causes pre-glomerular vasodilatation and post-glomerular vasoconstriction in rat kidney. Nature 324, 470–476 (1986).
Potter, L. R., Abbey-Hosch, S. & Dickey, D. M. Natriuretic peptides, their receptors, and cyclic guanosine monophosphate-dependent signaling functions. Endocr. Rev. 27, 47–72 (2006).
Nakamoto, M., Shapiro, J. I., Shanley, P., Chan, L. & Schrier, R. W. The in vitro and in vivo protective effect of atriopeptin III on ischemic acute renal failure. J. Clin. Invest. 80, 698–705 (1987).
Conger, J. D., Falk, S. A., Yuan, B. H. & Schrier R. W. Atrial natriuretic peptide and dopamine in a rat model of ischemic acute renal failure. Kidney Int. 35, 1126–1132 (1989).
Rahman, S. N. et al. Effects of atrial natriuretic peptide in clinical acute renal failure. Kidney Int. 45, 1731–1738 (1994).
Allgren, R. L. et al. Anaritide in acute tubular necrosis. N. Engl. J. Med. 336, 828–834 (1997).
Rahman, S. N. & Conger, J. D. Glomerular and tubular factors in urine flow rates of acute renal failure patients. Am. J. Kidney Dis. 23, 788–793 (1994).
Lewis, J. et al. Atrial natriuretic factor in oliguric acute renal failure. Am. J. Kidney Dis. 36, 767–774 (2000).
Swärd, K., Valsson, F., Odencrants, P., Samuelsson, O. & Rickstein, S. E. Recombinant human atrial natriuretic peptide in ischemic acute renal failure: A randomized placebo-controlled trial. Crit. Care Med. 32, 1310–1315 (2004).
Mentzer, R. M. Jr et al. Effects of perioperative nesiritide in patients with left ventricular dysfunction undergoing cardiac surgery: the NAPA Trial. J. Am. Coll. Cardiol. 49, 716–726 (2007).
Murray, P. Brain natriuretic peptide therapy to prevent acute kidney injury after cardiac surgery. Am. J. Kidney Dis. 51, 5–9 (2008).
Pan, S. et al. Biodesign of a renal-protective peptide based on alternative splicing of B-type natriuretic peptide. Proc. Natl Acad. Sci. USA 1006, 11282–11287 (2009).
Author information
Authors and Affiliations
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Schrier, R. Early intervention in acute kidney injury. Nat Rev Nephrol 6, 56–59 (2010). https://doi.org/10.1038/nrneph.2009.170
Issue Date:
DOI: https://doi.org/10.1038/nrneph.2009.170